Unjha Formulations bulk deals, insider trading and stake changes
BSE: 531762Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹29.05.
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹12 Cr4,689th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 3 Aug 2026
- 26.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 18 May 2026
- 3.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 3 Aug 2026
- 13.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 3 Aug 2026
- 15.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 18 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,887
Unjha Formulations insider trading
1 disclosure on record. The company's own latest disclosure on record is from Mar 2023.Insider trading, all companies
Mar 2023
- KRUTIBEN MAYANKKUMAR PATEL5,65,751sharesReceived · Connected Person · 14 Mar 2023 · Others · stake 2.27% before, 14.89% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Unjha Formulations stake sales and purchases
1 disclosure on record.
Mar 2023
- AcquiredKrutiben Mayankkumar Patel & PACs · promoter12.63% of the company5,65,751 sharesholds 14.89% after14 Mar 2023 · filed under the 2% rule
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Unjha Formulations bulk deals
None in the last 12 months, since 23 Oct 2025.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Monday 4 Nov 20241 firm · ₹0.11 Cr bought · ₹0.12 Cr soldNet nil
- Both waysUSHA JAWAHARLAL KALROBought 33,354 at ₹33.80Sold 33,354 at ₹34.990.74% of the companyNet nil₹0.11 Cr bought
Wednesday 7 Aug 20241 firm · ₹0.06 Cr bought · ₹0.07 Cr soldNet sold ₹0.02 Cr
- Both waysMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBought 20,161 at ₹28.32Sold 25,515 at ₹28.320.57% of the companyNet −5,354 shares₹0.06 Cr bought
Tuesday 6 Feb 20241 firm · ₹0.06 Cr bought · ₹0 soldNet bought ₹0.06 Cr
- BoughtSATYA PRAKASH MITTAL HUFBought 27,333 at ₹22.520.61% of the company₹0.06 Cr
Tuesday 13 Dec 20221 firm · ₹0 bought · ₹0.08 Cr soldNet sold ₹0.08 Cr
- SoldPRADEEP KUMAR JAINSold 59,535 at ₹12.601.33% of the company₹0.08 Cr
Tuesday 6 Jul 20212 firms · ₹0.05 Cr bought · ₹0.05 Cr soldNet nil
- Both waysBHARAT HASTIMAL JAIN HUFBought 39,492 at ₹11.49Sold 1,772 at ₹11.870.88% of the companyNet +37,720 shares₹0.05 Cr bought
- SoldPURSHOTTAM AGARWALSold 37,612 at ₹11.500.84% of the company₹0.04 Cr
Monday 21 Jun 20213 firms · ₹0 bought · ₹0.11 Cr soldNet sold ₹0.11 Cr
- SoldNARENDRAKUMAR BHAGWANDAS GUPTASold 43,065 at ₹11.090.96% of the company₹0.05 Cr
- SoldKAILASHBEN ASHOKKUMAR PATELSold 35,000 at ₹11.160.78% of the company₹0.04 Cr
- SoldPURSHOTTAM AGARWALSold 23,000 at ₹11.200.51% of the company₹0.03 Cr
Thursday 17 Jun 20212 firms · ₹0.02 Cr bought · ₹0.03 Cr soldNet nil
- SoldSUSHILA DEVI AGARWALSold 27,612 at ₹9.650.62% of the company₹0.03 Cr
- Both waysBHAVESH BHARAT JAIN (HUF)Bought 25,618 at ₹9.65Sold 2,000 at ₹10.230.57% of the companyNet +23,618 shares₹0.02 Cr bought
Friday 22 Jan 20212 firms · ₹0.03 Cr bought · ₹0.02 Cr soldNet bought ₹55,055
- BoughtPURSHOTTAM AGARWALBought 30,000 at ₹9.870.67% of the company₹0.03 Cr
- SoldSAMIR NARENDRA GUPTASold 24,422 at ₹9.870.55% of the company₹0.02 Cr
Tuesday 19 Jan 20211 firm · ₹0.02 Cr bought · ₹0 soldNet bought ₹0.02 Cr
- BoughtSUSHILA DEVI AGARWALBought 25,000 at ₹9.810.56% of the company₹0.02 Cr
Friday 15 Jan 20211 firm · ₹0.02 Cr bought · ₹0 soldNet bought ₹0.02 Cr
- BoughtPURSHOTTAM AGARWALBought 25,000 at ₹9.480.56% of the company₹0.02 Cr
Tuesday 12 Jan 20211 firm · ₹0.02 Cr bought · ₹0 soldNet bought ₹0.02 Cr
- BoughtPURSHOTTAM AGARWALBought 25,000 at ₹9.480.56% of the company₹0.02 Cr
Thursday 7 Jan 20212 firms · ₹0.02 Cr bought · ₹0.02 Cr soldNet nil
- SoldGANGEYA INVESTMENT CONSULTANTSSold 24,060 at ₹8.550.54% of the company₹0.02 Cr
- BoughtNARENDRAKUMAR BHAGWANDAS GUPTABought 24,000 at ₹8.550.54% of the company₹0.02 Cr
Thursday 1 Jun 20171 firm · ₹0 bought · ₹0.04 Cr soldNet sold ₹0.04 Cr
- SoldNILESH BHAGWATSold 31,035 at ₹13.350.69% of the company₹0.04 Cr
Thursday 3 Nov 20161 firm · ₹0 bought · ₹0.03 Cr soldNet sold ₹0.03 Cr
- SoldPRASANNA MN KSold 24,345 at ₹13.920.54% of the company₹0.03 Cr
Wednesday 5 Oct 20162 firms · ₹0.05 Cr bought · ₹0.06 Cr soldNet sold ₹61,600
- SoldSNEHALATHA SINGHISold 50,866 at ₹11.001.14% of the company₹0.06 Cr
- BoughtGANGEYA INVESTMENT CONSULTANTSBought 45,266 at ₹11.001.01% of the company₹0.05 Cr
Thursday 3 Jan 20081 firm · ₹0.03 Cr bought · ₹0 soldNet bought ₹0.03 Cr
- BoughtVARSHA BIPIN DHANNAWATBought 25,000 at ₹11.35₹0.03 Cr
Monday 31 Dec 20071 firm · ₹0.02 Cr bought · ₹0 soldNet bought ₹0.02 Cr
- BoughtALTAFHUSAIN MANSURIBought 22,527 at ₹9.77₹0.02 Cr
Monday 12 Nov 20071 firm · ₹0 bought · ₹0.01 Cr soldNet sold ₹0.01 Cr
- SoldSALIM ABDULGANI MEMANSold 25,800 at ₹5.31₹0.01 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 29 deals on record from 4 Jan 2004.